title: Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes early vascularization of implanted porous polyethylene (Medpor®).
abstract: Porous polyethylene (Medpor®) is frequently used in craniofacial reconstructive surgery. Rapid vascularization of the biomaterial crucially contributes to its adequate incorporation without complications. Macrophage-activating lipopeptide-2 (MALP-2) is a toll-like receptor (TLR)-2/6 agonist with pro-angiogenic properties. Herein we analyzed whether local single-shot application of MALP-2 improves the angiogenic host tissue response to Medpor®. Medpor® (3 mm×3 mm×0.25 mm) was implanted into dorsal skinfold chambers of BALB/c mice topically exposed to different MALP-2 doses (0.1 and 0.5 μg) or vehicle (control). The vascularization of the implants and the inflammatory foreign body reaction was analyzed using intravital fluorescence microscopy, histology and immunohistochemistry over 14 days. MALP-2 treatment dose-dependently improved the vascularization of Medpor®, as indicated by a significantly higher functional microvessel density at the border and center of the implants when compared to controls. This was associated with a temporary increase of adherent leukocytes in host tissue venules during the first 3 days after implantation. At day 14, implants in MALP-2-treated chambers were surrounded by granulation tissue, which exhibited a significantly higher density of CD31-positive microvessels and number of F4/80-positive macrophages when compared to controls. Additional biomaterial-free chambers did not show any signs of angiogenesis when treated with MALP-2. This indicates that locally applied MALP-2 effectively stimulates the early vascularization of Medpor® without inducing any local or systemic side effects. Accordingly, this easy approach may further improve the rapid incorporation of this biomaterial at the implantation site.
authors: Institute for Clinical & Experimental Surgery, University of Saarland, 66421 Homburg/Saar, Germany. Electronic address: matthias.laschke@uks.eu.
authors: M W
authors: MW
authors: Laschke
authors: Institute for Clinical & Experimental Surgery, University of Saarland, 66421 Homburg/Saar, Germany.
authors: V
authors: V
authors: Augustin
authors: Institute for Clinical & Experimental Surgery, University of Saarland, 66421 Homburg/Saar, Germany.
authors: S
authors: S
authors: Kleer
authors: Institute of Anatomy, University of Saarland, 66421 Homburg/Saar, Germany.
authors: T
authors: T
authors: Tschernig
authors: Institute for Clinical & Experimental Surgery, University of Saarland, 66421 Homburg/Saar, Germany.
authors: M D
authors: MD
authors: Menger
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology; D006097:Granulation Tissue / Q000187:drug effects / Q000473:pathology; D007962:Leukocytes / Q000187:drug effects / Q000473:pathology; D055666:Lipopeptides / Q000008:administration & dosage* / Q000494:pharmacology*; D008297:Male; D008807:Mice, Inbred BALB C; D008856:Microscopy, Fluorescence; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011095:Polyethylenes / Q000494:pharmacology*; D016062:Porosity; D019736:Prostheses and Implants; D012039:Regional Blood Flow / Q000187:drug effects
chemical_list: D001672:Biocompatible Materials; D055666:Lipopeptides; C084562:Medpor; D011095:Polyethylenes; C106335:macrophage stimulatory lipopeptide 2
keywords: Dorsal skinfold chamber; Incorporation; MALP-2; Polyethylene; Vascularization